Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis

BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases leading to renal failure. FSGS has a high risk of recurrence after kidney transplantation. Prevention of recurrent FSGS using rituximab and/or plasmapheresis has been evaluated in multiple small studi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:World J Transplant
Egile Nagusiak: Boonpheng, Boonphiphop, Hansrivijit, Panupong, Thongprayoon, Charat, Mao, Shennen A, Vaitla, Pradeep K, Bathini, Tarun, Choudhury, Avishek, Kaewput, Wisit, Mao, Michael A, Cheungpasitporn, Wisit
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Inc 2021
Gaiak:
Meta-Analysis
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8291000/
https://ncbi.nlm.nih.gov/pubmed/34316454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5500/wjt.v11.i7.303
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak